文献速递甲状腺疾病

组成性激活ALK突变诱导小鼠低分化甲状腺癌

Increased Anaplastic Lymphoma Kinase Activity Induces a Poorly Differentiated Thyroid Carcinoma in Mice.
PubMed 文献 · Thyroid · 2019-10-08

研究使用甲状腺细胞特异性表达组成性激活ALK突变(F1174L)的小鼠模型,观察到甲状腺显著增大、滤泡结构丧失、Tg和Nkx-2.1表达下降及甲状腺激素合成受损,组织学表现为类似人类低分化甲状腺癌(PDTC)的癌,伴甲状腺外侵犯和肺转移,中位生存期缩短至5个月。左甲状腺素替代维持正常甲状腺功能后肿瘤特征不变,表明PDTC发生由ALK活性增高驱动而非依赖TSH刺激。

要点

  • 甲状腺细胞表达激活型ALK突变可驱动小鼠发生类似人类PDTC的癌。
  • 肿瘤出现去分化、甲状腺外侵犯和肺转移,中位生存期缩短至5个月。
  • 左甲状腺素替代维持正常甲状腺功能后肿瘤特征不变,提示不依赖TSH。

核心结论

  • 在小鼠甲状腺中表达组成性激活的ALK突变可导致发生类似人类PDTC的转移性甲状腺癌,证明ALK活性增高是甲状腺癌发生的驱动机制。

研究设计与样本

  • 将携带Cre激活的组成性激活ALK突变(F1174L)等位基因的小鼠与在甲状腺球蛋白基因启动子控制下表达他莫昔芬诱导型Cre重组酶(CreERT2)的小鼠杂交,实现甲状腺细胞特异性表达ALK突变(ALKF1174L小鼠)。
  • 记录生存、血清甲状腺激素浓度和肿瘤发展,对甲状腺和肺进行组织学检查;一组队列通过饮水给予左甲状腺素(LT4)替代以在甲状腺去分化情况下维持甲状腺功能正常。

主要发现

  • ALKF1174L小鼠他莫昔芬注射后12周出现甲状腺显著增大和正常滤泡结构早期丧失。
  • Tg和Nkx-2.1表达显著下降及甲状腺激素合成受损,证实去分化。
  • 组织学显示类似人类PDTC的癌,以梁状/实性生长模式为主,核分裂率增加。
  • 肿瘤向周围带状肌甲状腺外延伸并发生肺转移。
  • ALKF1174L小鼠他莫昔芬注射后中位生存期显著缩短至5个月。

关键数值与推荐

  • Tg表达下降和滤泡结构丧失导致甲状腺功能减退伴促甲状腺激素(TSH)升高。
  • 通过LT4替代维持甲状腺功能正常的ALKF1174L小鼠发生的PDTC与甲状腺功能减退小鼠组织学特征相同,表明PDTC发生由ALK活性增高所致而不依赖TSH刺激。

临床怎么用

  • 本研究为动物模型结果,提示ALK活性增高是甲状腺癌发生的驱动机制,支持在甲状腺癌中进一步研究ALK作为潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Radioiodine refractory dedifferentiated thyroid cancer is a major clinical challenge. Anaplastic lymphoma kinase (ALK) mutations with increased ALK activity, especially fusion genes, have been suggested to promote thyroid carcinogenesis, leading to development of poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma. To determine the oncogenic potential of increased ALK activity in thyroid carcinogenesis in vivo, we studied mice with thyrocyte-specific expression of a constitutively active ALK mutant. Methods: Mice carrying a Cre-activated allele of a constitutively active ALK mutant (F1174L) were crossed with mice expressing tamoxifen-inducible Cre recombinase (CreERT2) under the control of the thyroglobulin (Tg) gene promoter to achieve thyrocyte-specific expression of the ALK mutant (ALKF1174L mice). Survival, thyroid hormone serum concentration, and tumor development were recorded. Thyroids and lungs were studied histologically. To maintain euthyroidism despite dedifferentiation of the thyroid, a cohort was substituted with levothyroxine (LT4) through drinking water. Results: ALKF1174L mice developed massively enlarged thyroids, which showed an early loss of normal follicular architecture 12 weeks after tamoxifen injection. A significant decrease in Tg and Nkx-2.1 expression as well as impaired thyroid hormone synthesis confirmed dedifferentiation. Histologically, the mice developed a carcinoma resembling human PDTC with a predominantly trabecular/solid growth pattern and an increased mitotic rate. The tumors showed extrathyroidal extension into the surrounding strap muscles and developed lung metastases. Median survival of ALKF1174L mice was significantly reduced to five months after tamoxifen injection. Reduced Tg expression and loss of follicular structure led to hypothyroidism with elevated thyrotropin (TSH). To test whether TSH stimulation played a role in thyroid carcinogenesis, we kept ALKF1174L mice euthyroid by LT4 substitution. These mice developed PDTC with identical histological features compared with hypothyroid mice, demonstrating that PDTC development was due to increased ALK activity and not dependent on TSH stimulation. Conclusion: Expression of a constitutively activated ALK mutant in thyroids of mice leads to development of metastasizing thyroid cancer resembling human PDTC. These results demonstrate in vivo that increased ALK activity is a driver mechanism in thyroid carcinogenesis.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Kohler H, Latteyer S, Hönes GS, et al. Increased Anaplastic Lymphoma Kinase Activity Induces a Poorly Differentiated Thyroid Carcinoma in Mice. Thyroid. 2019. PMID: 31526103. doi:10.1089/thy.2018.0526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。